About us

The Network Mission

Our network has one vision; to to discover and implement effective diagnostic and treatments for lung cancers through multi-collaborative research. In order to achieve this we have established the Lung Cancer Research Network. 

  • The Lung Cancer Research Network will bring together teams from hospitals, universities, networks and medical research institutes to focus on a common goal – multi-disciplinary teams developing an integrated approach to studying and treating lung cancers.
  • The Network will work with the Centre for Lung Cancer Research to meet this identified gap by promoting and coordinating large translational research programs within the field.

Centralised Support

The Lung Cancer Research Network is supported through the Woolcock Centre for Lung Cancer Research. This NSW State Health funded state-of-the-art-facility provides a research hub for network members, offers advanced data biobank storage and is a meeting place for our members. You can learn more about our new Centre here.

Making a Difference

Data generated from the Centre’s research will grow across the Network allowing researchers to go from ‘bedside to bench and back again’. With our centralised, coordinated and collaborative approach, the Network and its Centre will plug the gap in respiratory cancer research. In doing so, it will save lives and change the treatment landscape for sufferers and their families.

Our Track Record.

The Original Network Members come from over 20 world-class research teams. These teams have a proven track record in research and clinical excellence and:

  • They see 7,000 respiratory and cancer patients a year
  • They have published 2,200 peer-reviewed journal articles between them
  • Their research across cancer biology, drug discovery, drug delivery clinical management and treatment has attracted more than $120 million in grant income over the past five years
  • They have graduated more than 130 higher degree research students in the same period

With this experience and reach, they’re perfectly placed to engage with patients, funders and industry and fuel desperately-needed growth in lung cancer research.